Catalent and Blackstone Complete Secondary Offering
09.14.16
This is only gets display when printing
Simpson Thacher represented Catalent, Inc. and Blackstone Healthcare Partners L.L.C., an affiliate of The Blackstone Group, L.P., in connection with a secondary offering of the remaining 18,991,827 shares of common stock held by the selling stockholders at a public offering price of $23.85, resulting in gross proceeds of approximately $453 million to the selling stockholders. The offering closed on September 9, 2016.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.
The Simpson Thacher team included Ed Tolley, Xavier Kowalski and Tracy Ke (Capital Markets); James Rapp and Joia Lee (Public Company Advisory Practice); and John Torrenti (Tax).